Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | IL-1 alpha | 100 | ng/mL | 1 | b-NGF | 104.0 | 39 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | b-NGF | 196.0 | 59 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | b-NGF | 103.5 | 44 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | b-NGF | 94.0 | 55 | |
N2586 | IL-1 alpha | 100 | ng/mL | 1 | b-NGF | 142.0 | 49 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 69.0 | 47 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 30.0 | 49 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 42.0 | 40 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 35.0 | 57 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 46.0 | 49 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 75.0 | 39 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 52.0 | 63 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 24.0 | 42 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 77.0 | 51 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 92.0 | 43 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 63.0 | 46 | |
N2759 | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 61.0 | 67 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 103.5 | 46 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 50.5 | 40 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 96.0 | 59 | |
N2586 | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 118.0 | 53 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | b-NGF | 76.0 | 57 | ||||
RA1869 | IKK16 | 2.0 | uM | 1 | b-NGF | 42.0 | 50 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | b-NGF | 36.0 | 40 | ||||
N2759 | IKK16 | 2.0 | uM | 1 | b-NGF | 31.0 | 49 |